3
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Differential Stability of c-myc mRNAS in a Cell-Free System

&
Pages 2860-2868 | Received 13 Jan 1988, Accepted 29 Mar 1988, Published online: 31 Mar 2023

LITERATURE CITED

  • Barnard, E. A. 1969. Ribonucleases. Annu. Rev. Biochem. 38:677–732.
  • Belasco, J. G., J. T. Beatty, C. W. Adams, A. Gabain, and S. N. Cohen. 1985. Differential expression of photosynthesis genes in R. capsulata results from segmental differences in stability within the polycistronic rxcA transcript. Cell 40:171–181.
  • Bernard, O., S. Cory, S. Gerondakis, E. Webb, and J. Adams. 1983. Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumors. EMBO J. 2:2375–2383.
  • Blanchard, J. M., M. Piechaczyk, C. Dani, J. C. Chambard, A. Franchi, J. Pouyssegur, and P. Jeanteur. 1985. c-myc gene is transcribed at high rate in GO-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors. Nature (London) 317:443–445.
  • Brock, M. L., and D. J. Shapiro. 1983. Estrogen stabilizes vitellogenin mRNA against cytoplasmic degradation. Cell 34:207–214.
  • Calame, K. 1985. Mechanisms that regulate immunoglobulin gene expression. Annu. Rev. Immunol. 3:159–195.
  • Cole, M. D. 1986. The myc oncogene: its role in transformation and differentiation. Annu. Rev. Genet. 20:361–384.
  • Dani, C., J. M. Blanchard, M. Pichaczyk, S. E. Sabouty, L. Marty, and P. Jeanteur. 1984. Extreme instability of myc mRNA in normal and transformed human cells. Proc. Natl. Acad. Sci. USA 81:7046–7050.
  • Dani, C., M. Piechazyk, P. Jeanteur, and J. M. Blanchard. 1985. Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells. Proc. Natl. Acad. Sci. USA 82:4896–4899.
  • Dony, C., M. Kessel, and P. Gruss. 1985. Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9. Nature (London) 317:636–639.
  • Drummond, R. D., J. Armstrong, and A. Colman. 1985. The effect of capping and polyadenylation on the stability, movement and translation of synthetic messenger RNAs in Xenopus oocytes. Nucleic Acids Res. 13:7375–7393.
  • Early, P. W., M. Davis, D. B. Kaback, N. Davidson, and L. Hood. 1979. Immunoglobulin heavy chain gene organization in mice: analysis of a myeloma genomic clone containing variable and a constant regions. Proc. Natl. Acad. Sci. USA 76:857–861.
  • Eick, D., M. Piechaczyk, B. Henglein, J. M. Blanchard, B. Traub, E. Kofler, S. Wiest, G. M. Lenoir, and G. W. Bornkamm. 1985. Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives. EMBO J. 4:3717–3725.
  • Endo, T., and B. N. Ginard. 1986. Transcriptional and posttran-scriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and dose not suppress the differentiated phenotype. Mol. Cell. Biol. 6:1412–1421.
  • Fort, P., L. Marty, M. Piechaczyk, S. E. Sabrouty, C. Dani, P. Jeanteur, and J. M. Blanchard. 1985. Various rat adult tissues express only one major mRNA species from the glyceral-dehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1431–1442.
  • Gay, D. A., T. J. Yen, J. T. Lau, and D. W. Cleveland. 1987. Sequences that confer β-tubulin autoregulation through modulated mRNA stability reside within exon 1 of a β-tubulin mRNA. Cell 50:671–679.
  • Guyette, W. A., R. J. Matusik, and J. M. Rosen. 1979. Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression. Cell 17:1013–1023.
  • Howe, C. C., D. K. Lugg, and C. Overton. 1984. Post-transcriptional regulation of the abundance of mRNAs encoding atubulin and a 94,000-dalton protein in teratocarcinoma-derived stem cells versus differentiated cells. Mol. Cell. Biol. 4:2428–2436.
  • Jones, T. R., and M. D. Cole. 1987. Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3′ untranslated sequences. Mol. Cell. Biol. 7:4513–4521.
  • Khalili, K., and R. Weinmann. 1984. Actin mRNAs in Hela cells. J. Mol. Biol. 180:1007–1021.
  • Knight, J., E. D. Anton, D. Fahey, B. K. Friedland, and G. J. Jonak. 1985. Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. Proc. Natl. Acad. Sci. USA 82:1151–1154.
  • Kohler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (London) 256:495–197.
  • Levine, R. A., J. E. McCormack, A. Buckler, and G. E. Sonenshein. 1986. Transcriptional and posttranscriptional control of c-myc gene expression in WEHI 231 cells. Mol. Cell. Biol. 6:4112–4116.
  • Melton, A., P. A. Krieg, M. R. Rebagliati, T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage Sp6 promoter. Nucleic Acids Res. 12:7035–7056.
  • Newbury, S. F., N. H. Smith, E. C. Robinson, I. D. Hiles, and C. F. Higgins. 1987. Stabilization of translationally active mRNA by prokaryotic REP sequences. Cell 46:287–310.
  • Nielsen, D. A., and D. J. Shapiro. 1986. Preparation of capped RNA transcripts using T7 polymerase. Nucleic Acids Res. 14:59–36.
  • Nilsson, G., J. G. Belasco, S. N. Cohen, and A. V. Gabain. 1984. Growth-rate dependent regulation of mRNA stability in Escherichia coli. Nature (London) 312:75–77.
  • Paek, L., and R. Axel. 1987. Glucocorticoids enhance stability of human growth hormone mRNA. Mol. Cell. Biol. 7:1496–1507.
  • Peltz, S. W., G. Brewer, G. Kobs, and J. Ross. 1987. Substrate specificity of the exonuclease activity that degrades H4 histone mRNA. J. Biol. Chem. 263:9382–9388.
  • Piechaczyk, M., J. M. Blanchard, L. Marty, C. Dani, F. Panahieres, S. El Sabouty, P. Fort, and P. Jeanteur. 1984. Posttranscriptional regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression in rat tissues. Nucleic Acids Res. 12:6951–6963.
  • Piechaczyk, M., A. Bonnieu, D. Eick, E. Remmers, J. Q. Yang, K. Marcu, P. Jeanteur, and J. M. Blanchard. 1986. Altered c-myc RNA metabolism in Burkitt's lymphomas and Mouse plasmacytomas. Curr. Top. Microbiol. Immunol. 132:331–338.
  • Piechaczyk, M., J. Q. Yang, J. M. Blanchard, P. Jeanteur, and K. B. Marcu. 1985. Posttranscriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumors. Cell 42:589–597.
  • Prehn, J., M. Mercola, and K. Calame. 1984. Translocation affects normal c-myc promoter usage and activates fifteen cryptic c-myc transcription starts in plasmacytoma M603. Nucleic Acids Res. 12:8987–9007.
  • Rabbitts, P. H., A. Forster, M. A. Stinson, and T. H. Rabbitts. 1985. Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNA stability. EMBO J. 4:3727–3733.
  • Rome, L., and L. R. Grain. 1981. Degradation of mucopolysach-aride in intact isolated lysosomes. J. Biol. Chem. 256:10763–10768.
  • Ross, J., and G. Kobs. 1986. H4 histone messenger RNA decay in cell-free extracts initiates at or near the 3′ terminus and proceeds 3′ to 5′. J. Mol. Biol. 188:579–593.
  • Schek, N., and S. L. Bachenheimer. 1985. Degradation of cellular mRNAs induced by a virion-associated factor during herpes simplex virus infection of Vero cells. J. Virol. 55:601–610.
  • Shaw, G., and K. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659–667.
  • Stanton, L. W., P. D. Farhlander, and K. B. Marcu. 1984. Nucleotide sequence comparison of normal and translocated murine c-myc gene. Nature (London) 310:423–425.
  • Suissa, M. 1983. Spectrophotometric quantitation of silver grain eluted from autoradiograms. Anal. Biochem. 133:511–514.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.